Hjem › Ikke-småcellet lungekreft › Arkansas › Springdale
Kliniske studier for Ikke-småcellet lungekreft i Springdale, AR
15 studier for Ikke-småcellet lungekreft søker deltakere på steder i og rundt Springdale (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
RekruttererFase 2/3
- Highlands Oncology Group - Springdale /ID# 277132, Springdale
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
RekruttererFase 3
- Highlands Oncology Group, PA, Springdale
- Highlands Oncology Group, Springdale
- Highlands Oncology Group, PA, Rogers · 10 mi unna
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
RekruttererFase 3
- Highlands Oncology Group-Research Department ( Site 0062), Springdale
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekruttererFase 3
- Highlands Oncology Group, Springdale
- Highlands Oncology Group, Rogers · 10 mi unna
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
RekruttererFase 1/2
- Highlands Oncology Group, PA, Springdale
- Highlands Oncology Group, PA, Rogers · 10 mi unna
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
RekruttererFase 3
- Highlands Oncology Group, Springdale
Pan-tumor MRD Study
RekruttererObservasjonsstudie
- Highlands Oncology Group (HOG), Springdale
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
RekruttererFase 3
- Research Site, Springdale
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
RekruttererFase 3
- Local Institution - 0686, Springdale
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
RekruttererFase 3
- Research Site, Springdale
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RekruttererFase 2/3
- Highlands Oncology Group - Springdale, Springdale
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekruttererFase 3
- Highlands Oncology Group, Springdale
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In
RekruttererFase 3
- Highlands Oncology Group, Springdale
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RekruttererFase 1
- Highlands Oncology Group, Springdale
- Highlands Oncology Group, Rogers · 10 mi unna
BostonGene and Exigent Genomic INsight Study
RekruttererObservasjonsstudie
- Highlands Oncology Group, Rogers · 10 mi unna
Ikke-småcellet lungekreft-studier i andre byer
- Houston, TX145 studier
- New York City, NY121 studier
- Arlington, VA104 studier
- Nashville, TN97 studier
- Boston, MA90 studier
- Los Angeles, CA87 studier
- St. Louis, MO73 studier
- Chicago, IL61 studier
- Baltimore, MD60 studier
- San Antonio, TX59 studier
- Columbus, OH57 studier
- Washington, DC55 studier
Andre studier i Springdale
- Schizofreni7 studier
- Lungekreft6 studier
- Metastatisk kreft6 studier
- Kolorektal kreft5 studier
- Brystkreft5 studier
- Kreft (alle typer)5 studier
- Major depresjon5 studier
- Blærekreft4 studier
- Depresjon4 studier
- Spiserørkreft3 studier
- Mani3 studier
- Plateepitelcancer i hode og hals3 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.